TITLE

Point-of-care testing of proteins

AUTHOR(S)
Warsinke, Axel
PUB. DATE
March 2009
SOURCE
Analytical & Bioanalytical Chemistry;Mar2009, Vol. 393 Issue 5, p1393
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Point-of-care testing (POCT) is a fast developing area in clinical diagnostics that is considered to be one of the main driving forces for the future in vitro diagnostic market. POCT means decentralized testing at the site of patient care. The most important POCT devices are handheld blood glucose sensors. In some of these sensors, after the application of less than 1 µl whole blood, the results are displayed in less than 10 s. For protein determination, the most commonly used devices are based on lateral flow technology. Although these devices are convenient to use, the results are often only qualitative or semiquantitative. The review will illuminate some of the current methods employed in POCT for proteins and will discuss the outlook for techniques (e.g., electrochemical immunosensors) that could have a great impact on future POCT of proteins.
ACCESSION #
36548688

 

Related Articles

  • Point-of-Care Products: Highlights, Trends, and Emerging Technologies. Ghosh, Madhushree // Clinical Lab Products;Sep2009, Vol. 39 Issue 9, p10 

    The article focuses on the development of point-of-care (POC) diagnostics in 2009. It is stated that Roche Diagnostics' ACCU-Chek Aviva system is a blood glucose meter which can be used by diabetic patients and with results in 5 seconds. The DCA Vantage Analyzer from Siemens Healthcare...

  • ACCUCHEK (TM) MEASUREMENT OF BLOOD GLUCOSE CORRELATES WITH TRUE LAB GLUCOSE MEASUREMENT IN CHILDREN SCREENED FOR CYSTIC FIBROSIS RELATED DIABETES. Fall, A. J.; Mallinson, A.; Mill, A.; Urquhart, D. S. // Thorax;Dec2011 Supplement, pA166 

    Background Screening for cystic fibrosis related diabetes (CFRD) is recommended as part of the cystic fibrosis annual review. For children over 10 an oral glucose tolerance test (OGTT) is recommended, but this is time consuming and adds to the burden of assessments and investigations of the...

  • Validation of five point-of-care glucometers. Æelap, I.; Milevoj Kopèinoviæ, L.; Kosovec, V.; Grabusin, P.; Begèeviæ, I.; Vrkiæ, N. // Biochemia Medica;2014 Supplement, Vol. 24, pS72 

    Background: Self-monitoring of blood glucose is a convenient way in the management of patients with type 2 diabetes mellitus (T2DM). Although numerous glucometers are available in the market, only rare can achieve requested performance characteristics given by International Federation in...

  • Regulatory Update.  // CenterWatch Monthly;Dec2016, Vol. 23 Issue 12, p4 

    The article discusses the final guidance documents "Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use," and "Head Lice Infestation: Developing Drugs for Topical Treatment," published by the U.S. Food and Drug Administration (FDA) in October 2016.

  • Automation of the Consensus Guidelines in Diabetes Case: Potential Impact on Clinical Inertia. A. Albisser; Francine Inhaber // Endocrine Practice;Nov2010, Vol. 16 Issue 6, p992 

    Objective: To propose that automation of the consensus guidelines and mandated targets (CG&MT) in glycemia, hemoglobin A1c, and body weight will facilitate optimal clinical management of patients with diabetes.Methods: (1) A simplified method for capturing diabetes outcomes at home was devised,...

  • Epocal gets FDA clearance of glucose test on epoc system.  // Medical Device Daily;8/24/2009, Vol. 13 Issue 162, p8 

    The article reports on the clearance issued by the U.S. Food & Drug Administration (FDA) for Epocal to market its glucose test on the epoc Blood Analysis System. It is noted that the addition of the glucose test on the epoc brand expands the clinical use of the company's point-of-care blood gas...

  • Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm. Jungheim, Karsten; Koschinsky, Theodor // Diabetes Care;Jul2001, Vol. 24 Issue 7, p1303 

    Presents a study which examined whether fast blood glucose changes over a larger range of blood glucose concentrations could result in clinically relevant blood glucose differences between forearm and fingertip. Discrepancies between clinical symptoms of hypoglycemia and normoglycemic...

  • Glucose monitors: More choices than ever. Wynn, Paul // Drug Topics;10/6/2003 Supplement, Vol. 147 Issue 19, p22s 

    Describes advances in blood glucose monitoring in the U.S. Computer technology incorporated into blood glucose monitors; Insulin pumps with blood glucose monitoring systems; Approaches to continuously blood glucose monitoring.

  • continuous glucose monitoring.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p515 

    A definition of the term "continuous glucose monitoring," which refers to the measurement of blood sugar, is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics